Sci-Tech Today: Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today: Africa.

Press releases published on September 8, 2026

Sep. 8, 2026

Collegium to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Walden Biosciences to Participate in 24th Annual Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program

Indeterminate GlobeNewswire

Sep. 8, 2026

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

TruGolf Announces Binding Distribution MOU with TruGolf Canada Inc. Covering Defined Canadian and Indigenous Market Opportunities

Indeterminate GlobeNewswire

Sep. 8, 2026

MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire

Sep. 8, 2026

PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Rani Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group

Indeterminate GlobeNewswire

Sep. 8, 2026

Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations

Indeterminate GlobeNewswire

Sep. 8, 2026

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire

Sep. 8, 2026

Aduro Clean Technologies to Present Hydrochemolytic™ Technology for Polyolefin Recycling at Chemical Recycling Europe Annual Conference 2026

Indeterminate GlobeNewswire

Sep. 8, 2026

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

Sep. 8, 2026

NowVertical Expands Google Cloud Practice into Brazil

Indeterminate GlobeNewswire

Sep. 8, 2026

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire